E2F1 and prostate cancer: In bladder and prostate cancer cell lines, E2F1 enhanced cancer cell glycolysis by directly binding to the proximal SIRT6 promoter and suppressed SIRT6 expression, as well as significantly enhanced glucose uptake and lactate production [45].